2007
DOI: 10.1007/s10792-007-9085-2
|View full text |Cite
|
Sign up to set email alerts
|

Mitomycin C and conjunctival autograft for recurrent pterygium

Abstract: Intraoperative application of 0.2 mg/ml Mitomycin-C combined with conjunctival autograft reduces recurrence in recurrent pterygium cases, with minimal complications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
2
0
2

Year Published

2009
2009
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 33 publications
1
2
0
2
Order By: Relevance
“…We believe this stems from the use of MMC, which suppresses recurrence and improves cosmetic appearance (white eye) when applied properly. [1618] Additionally, none of our patients experienced symblepharon, a result consistent with previous reports of inferior conjunctival autograft transplantations. [81922] Although there have previously been reports of pseudopterygium at the superior or inferior limbal-conjunctival donor sites, none of our patients experienced this complication, which, again, is consistent with previous work using the limbal conjunctival transplantation.…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…We believe this stems from the use of MMC, which suppresses recurrence and improves cosmetic appearance (white eye) when applied properly. [1618] Additionally, none of our patients experienced symblepharon, a result consistent with previous reports of inferior conjunctival autograft transplantations. [81922] Although there have previously been reports of pseudopterygium at the superior or inferior limbal-conjunctival donor sites, none of our patients experienced this complication, which, again, is consistent with previous work using the limbal conjunctival transplantation.…”
Section: Discussionsupporting
confidence: 91%
“…These include “fibrovascular tissue crossing the limbus onto clear cornea in the area of previous pterygium excision” or other similar expressions, which we used when defining “recurrence” in this study. [57121820] These issues are reasons of controversy in the literature. Therefore, such issues make the evaluation of treatment more complicated and controversial.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Greft reperfüzyonunu geciktirebileceği için aşırı koterden kaçınıl-malıdır. 16 Çalışmamızda, 1 (%3,3) hastada birinci haftada gelişen granülasyon dokusu medikal tedavi ile düzelmiştir. Hastalarımızda preoperatif nüks piterjiyum olmaması, sütür kullanılması, minimal koter uygulaması, greftin ince ve tenondan arındı-rılmış olması gibi nedenlerden dolayı komplikasyonlarımızın az olduğu düşünülmektedir.…”
Section: Discussionunclassified
“…[5][6][7][8][9] Bu da MMC kullan›larak uygulanan cerrahiler sonras› hastalar›n uzun dönem yak›ndan takibini gerektirdi¤inden MMC kullan›m›-n› özellikle rekürren vakalara saklamak daha ak›lc› bir yol gibi gözükmektedir. 12 Bizim serimizdeki gözlerden 9'unda (%50) intraoperatif MMC uygulanm›fl olup hepsi de primer pterjiyumlard›r. Bu olgularda komplikasyon nisbeten erken say›labilecek bir dönemde (ortalama postoperatif 6,55±4,04 ay, minimum 2, maksimum 14 ay) ortaya ç›km›flt›r.…”
Section: Tart›flmaunclassified